Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): A systematic review

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Shenoy, Erica S ^a   Paras, Molly L ^a   Noubary, Farzad ^b   Walensky, Rochelle P ^c   Hooper, David C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b TUFTS UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Carrier; Colonization; Contact precautions; MRSA; VRE

Indexed keywords

ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; DATA ANALYSIS; DISEASE COURSE; ENTEROCOCCAL INFECTION; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION CONTROL; MEDICAL RESEARCH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORBIDITY; NOMENCLATURE; NONHUMAN; OBSERVATIONAL STUDY; POPULATION RESEARCH; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLING; SYSTEMATIC REVIEW; VANCOMYCIN RESISTANT ENTEROCOCCUS; GRAM POSITIVE INFECTION; HETEROZYGOTE; MICROBIOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS INFECTION;

CARRIER STATE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84899133158     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-177     Document Type: Article

References (56)

1. Jarvis WR, Jarvis AA, Chinn RY. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010. Am J Infect Control 2012, 40(3):194-200. 10.1016/j.ajic.2012.02.001, 22440670.
2. Zilberberg MD, Shorr AF, Kollef MH. Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005. Emerg Infect Dis 2008, 14(11):1756-1758. 10.3201/eid1411.080337, 2630735, 18976563.
3. Ramsey AM, Zilberberg MD. Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol 2009, 30(2):184-186. 10.1086/593956, 19125679.
4. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007, 13(12):1840-1846. 10.3201/eid1312.070629, 2876761, 18258033.
5. Shenoy ES, Walensky RP, Lee H, Orcutt B, Hooper DC. Resource burden associated with contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: the patient access Managers' perspective. Infect Control Hosp Epidemiol 2012, 33(8):849-852. 10.1086/666629, 3461826, 22759555.
6. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003, 290(14):1899-1905. 10.1001/jama.290.14.1899, 14532319.
7. Conterno LO, Shymanski J, Ramotar K, Toye B, van Walraven C, Coyle D, Roth VR. Real-time polymerase chain reaction detection of methicillin-resistant Staphylococcus aureus: impact on nosocomial transmission and costs. Infect Control Hosp Epidemiol 2007, 28(10):1134-1141. 10.1086/520099, 17828689.
8. Greenwood M. The natural duration of cancer. Rep Public Health Med Subj 1926, 33:1-26.
9. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses 2014, Ottowa Health Research Institute; L'Institut De Recherche en Sante D'Ottowa Web site, http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
10. Moher D, Liberati A, Tetzlaff J, Altman DG PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535. 10.1136/bmj.b2535, 2714657, 19622551, PRISMA Group.
11. Sanford MD, Widmer AF, Bale MJ, Jones RN, Wenzel RP. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1994, 19(6):1123-1128. 10.1093/clinids/19.6.1123, 7888543.
12. Mulhausen PL, Harrell LJ, Weinberger M, Kochersberger GG, Feussner JR. Contrasting methicillin-resistant Staphylococcus aureus colonization in Veterans Affairs and community nursing homes. Am J Med 1996, 100(1):24-31. 10.1016/S0002-9343(96)90007-8, 8579083.
13. O'Sullivan NR, Keane CT. The prevalence of methicillin-resistant Staphylococcus aureus among the residents of six nursing homes for the elderly. J Hosp Infect 2000, 45(4):322-329. 10.1053/jhin.2000.0758, 10973751.
14. Scanvic A, Denic L, Gaillon S, Giry P, Andremont A, Lucet JC. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001, 32(10):1393-1398. 10.1086/320151, 11317238.
15. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004, 39(7):971-979. 10.1086/423965, 15472848.
16. Cretnik TZ, Vovko P, Retelj M, Jutersek B, Harlander T, Kolman J, Gubina M. Prevalence and nosocomial spread of methicillin-resistant Staphylococcus aureus in a long-term-care facility in Slovenia. Infect Control Hosp Epidemiol 2005, 26(2):184-190. 10.1086/502524, 15756890.
17. Vriens MR, Blok HE, Gigengack-Baars AC, Mascini EM, van der Werken C, Verhoef J, Troelstra A. Methicillin-resistant Staphylococcus aureus carriage among patients after hospital discharge. Infect Control Hosp Epidemiol 2005, 26(7):629-633. 10.1086/502592, 16092743.
18. Marschall J, Muhlemann K. Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisition. Infect Control Hosp Epidemiol 2006, 27(11):1206-1212. 10.1086/507917, 17080378.
19. Ellis MW, Griffith ME, Dooley DP, McLean JC, Jorgensen JH, Patterson JE, Davis KA, Hawley JS, Regules JA, Rivard RG, Gray PJ, Ceremuga JM, Dejoseph MA, Hospenthal DR. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob Agents Chemother 2007, 51(10):3591-3598. 10.1128/AAC.01086-06, 2043273, 17682105.
20. Simor AE, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin HR, Kiss A. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007, 44(2):178-185. 10.1086/510392, 17173213.
21. Wendt C, Schinke S, Wurttemberger M, Oberdorfer K, Bock-Hensley O, von Baum H. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol 2007, 28(9):1036-1043. 10.1086/519929, 17932823.
22. Lucet JC, Paoletti X, Demontpion C, Degrave M, Vanjak D, Vincent C, Andremont A, Jarlier V, Mentre F, Nicolas-Chanoine MH Staphylococcus aureus Resistant a la Meticilline en Hospitalisation A Domicile (SARM HAD) Study Group Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members. Arch Intern Med 2009, 169(15):1372-1378. 10.1001/archinternmed.2009.217, 19667299, Staphylococcus aureus Resistant a la Meticilline en Hospitalisation A Domicile (SARM HAD) Study Group.
23. Robicsek A, Beaumont JL, Peterson LR. Duration of colonization with methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2009, 48(7):910-913. 10.1086/597296, 19231982.
24. Lautenbach E, Tolomeo P, Nachamkin I, Hu B, Zaoutis TE. The impact of household transmission on duration of outpatient colonization with methicillin-resistant Staphylococcus aureus. Epidemiol Infect 2010, 138(5):683-685. 10.1017/S0950268810000099, 2847002, 20109256.
25. Manzur A, Dominguez MA, Ruiz De Gopegui E, Mariscal D, Gavalda L, Segura F, Perez JL, Pujol M Spanish Network for Research in Infectious Diseases Natural history of methicillin-resistant Staphylococcus aureus colonization among residents in community long term care facilities in Spain. J Hosp Infect 2010, 76(3):215-219. 10.1016/j.jhin.2010.05.022, 20692073, Spanish Network for Research in Infectious Diseases.
26. van Velzen EV, Reilly JS, Kavanagh K, Leanord A, Edwards GF, Girvan EK, Gould IM, Mackenzie FM, Masterton R. A retrospective cohort study into acquisition of MRSA and associated risk factors after implementation of universal screening in Scottish hospitals. Infect Control Hosp Epidemiol 2011, 32(9):889. 10.1086/661280, 21828969.
27. Montecalvo MA, de Lencastre H, Carraher M, Gedris C, Chung M, VanHorn K, Wormser GP. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995, 16(12):680-685. 10.2307/30141910, 8683085.
28. Brennen C, Wagener MM, Muder RR. Vancomycin-resistant Enterococcus faecium in a long-term care facility. J Am Geriatr Soc 1998, 46(2):157-160.
29. Goetz AM, Rihs JD, Wagener MM, Muder RR. Infection and colonization with vancomycin-resistant Enterococcus faecium in an acute care Veterans Affairs Medical Center: a 2-year survey. Am J Infect Control 1998, 26(6):558-562. 10.1053/ic.1998.v26.a86286, 9836838.
30. Bhorade SM, Christenson J, Pohlman AS, Arnow PM, Hall JB. The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. Chest 1999, 115(4):1085-1091. 10.1378/chest.115.4.1085, 10208212.
31. Weinstein MR, Dedier H, Brunton J, Campbell I, Conly JM. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1999, 29(2):361-366. 10.1086/520216, 10476743.
32. D'Agata EM, Green WK, Schulman G, Li H, Tang YW, Schaffner W. Vancomycin-Resistant Enterococci among chronic hemodialysis patients: a prospective study of acquisition. Clin Infect Dis 2001, 32(1):23-29. 10.1086/317549, 11112676.
33. Wong MT, Kauffman CA, Standiford HC, Linden P, Fort G, Fuchs HJ, Porter SB, Wenzel RP Ramoplanin VRE2 Clinival Stury Group Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis 2001, 33(9):1476-1482. 10.1086/322687, 11588692, Ramoplanin VRE2 Clinival Stury Group.
34. Byers KE, Anglim AM, Anneski CJ, Farr BM. Duration of colonization with vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002, 23(4):207-211. 10.1086/502036, 12002235.
35. Hachem R, Raad I. Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2002, 23(1):43-44. 10.1086/501968, 11868893.
36. Mascini EM, Jalink KP, Kamp-Hopmans TE, Blok HE, Verhoef J, Bonten MJ, Troelstra A. Acquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type. J Clin Microbiol 2003, 41(12):5377-5383. 10.1128/JCM.41.12.5377-5383.2003, 308960, 14662914.
37. Huang SS, Rifas-Shiman SL, Pottinger JM, Herwaldt LA, Zembower TR, Noskin GA, Cosgrove SE, Perl TM, Curtis AB, Tokars JL, Diekema DJ, Jernigan JA, Hinrichsen VL, Yokoe DS, Platt R Centers for Disease Control and Prevention Epicenters Program Improving the assessment of vancomycin-resistant enterococci by routine screening. J Infect Dis 2007, 195(3):339-346. 10.1086/510624, 17205471, Centers for Disease Control and Prevention Epicenters Program.
38. Park I, Park RW, Lim SK, Lee W, Shin JS, Yu S, Shin GT, Kim H. Rectal culture screening for vancomycin-resistant Enterococcus in chronic haemodialysis patients: false-negative rates and duration of colonization. J Hosp Infect 2011, 79(2):147-150. 10.1016/j.jhin.2011.04.011, 21764175.
39. Yoon YK, Lee SE, Lee J, Kim HJ, Kim JY, Park DW, Sohn JW, Kim MJ. Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study. J Antimicrob Chemother 2011, 66(8):1831-1838. 10.1093/jac/dkr204, 21652622.
40. Siegel JD, Rhinehart E, Jackson M, Chiarello L Health Care Infection Control Practices Advisory Committee 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007, 35(10 Suppl 2):S65-S164. Health Care Infection Control Practices Advisory Committee.
41. Siegel JD, Rhinehart E, Jackson M, Chiarello L Healthcare Infection Control Practices Advisory Committee Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007, 35(10 Suppl 2):S165-S193. Healthcare Infection Control Practices Advisory Committee.
42. Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, Hutton-Thomas RA, Whalen CC, Bonomo RA, Rice LB. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000, 343(26):1925-1932. 10.1056/NEJM200012283432604, 11136263.
43. Bhalla A, Pultz NJ, Ray AJ, Hoyen CK, Eckstein EC, Donskey CJ. Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients. Infect Control Hosp Epidemiol 2003, 24(9):644-649. 10.1086/502267, 14510245.
44. Drees M, Snydman DR, Schmid CH, Barefoot L, Hansjosten K, Vue PM, Cronin M, Nasraway SA, Golan Y. Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2008, 29(8):709-715. 10.1086/589582, 18631116.
45. Donskey CJ, Hoyen CK, Das SM, Helfand MS, Hecker MT. Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy. Infect Control Hosp Epidemiol 2002, 23(8):436-440. 10.1086/502081, 12186208.
46. Karki S, Houston L, Land G, Bass P, Kehoe R, Borrell S, Watson K, Spelman D, Kennon J, Harrington G, Cheng AC. Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study. Antimicrob Resist Infect Control 2012, 1(1):31. 10.1186/2047-2994-1-31, 3523023, 23039285.
47. Iosifidis E, Evdoridou I, Agakidou E, Chochliourou E, Protonotariou E, Karakoula K, Stathis I, Sofianou D, Drossou-Agakidou V, Pournaras S, Roilides E. Vancomycin-resistant Enterococcus outbreak in a neonatal intensive care unit: epidemiology, molecular analysis and risk factors. Am J Infect Control 2013, 41(10):857-861. 10.1016/j.ajic.2013.02.005, 23669299.
48. Shenoy ES, Kim J, Rosenberg ES, Cotter JA, Lee H, Walensky RP, Hooper DC. Discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction. Clin Infect Dis 2013, 57(2):176-184. 10.1093/cid/cit206, 23572482.
49. Shenoy ES, Hsu H, Noubary F, Hooper DC, Walensky RP. National survey of infection preventionists: policies for discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2012, 33(12):1272-1275. 10.1086/668427, 3496276, 23143372.
50. Doebbeling BN, Wenzel RP. The direct costs of universal precautions in a teaching hospital. JAMA 1990, 264(16):2083-2087. 10.1001/jama.1990.03450160053028, 2170699.
51. Kim T, Oh PI, Simor AE. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001, 22(2):99-104. 10.1086/501871, 11232886.
52. Conterno LO, Shymanski J, Ramotar K, Toye B, Zvonar R, Roth V. Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum beta-lactamase-producing organisms in a non-outbreak setting. J Hosp Infect 2007, 65(4):354-360. 10.1016/j.jhin.2006.12.014, 17289215.
53. Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 2009, 37(2):85-93. 10.1016/j.ajic.2008.04.257, 3557494, 19249637.
54. Day HR, Morgan DJ, Himelhoch S, Young A, Perencevich EN. Association between depression and contact precautions in veterans at hospital admission. Am J Infect Control 2011, 39(2):163-165. 10.1016/j.ajic.2010.06.024, 3304097, 21356434.
55. McLemore A, Bearman G, Edmond MB. Effect of contact precautions on wait time from emergency room disposition to inpatient admission. Infect Control Hosp Epidemiol 2011, 32(3):298-299. 10.1086/658913, 21460519.
56. Harris AD, Furuno JP, Roghmann MC, Johnson JK, Conway LJ, Venezia RA, Standiford HC, Schweizer ML, Hebden JN, Moore AC, Perencevich EN. Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy. Antimicrob Agents Chemother 2010, 54(8):3143-3148. 10.1128/AAC.01590-09, 2916333, 20479207.